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Brain 4 (Brn4/Pou3f4) and Pax6 are POU-homeodomain and paired-homeodomain transcription factors, respectively, that are expressed
in the brain and the glucagon-expressing cells in the pancreas. Brn4 expression begins at embryonic day 10 in the pancreas, just before pax6
and both appear in the glucagon immunoreactive cells. At a later time point, E19, no Brn4 co-localization is observed with insulin or
somatostatin but a rare pancreatic polypeptide (PP)-producing cell can be found, while Pax6 is found in all endocrine cells. These data
suggest that brn4 is the only a-cell specific transcription factor yet identified; therefore, we sought to analyze a-cell development and
function in mice with a targeted disruption of the brn4 gene. In homozygous brn4 / mice, pancreatic bud formation, glucagon cell numbers
and physiological measurements all appear normal. Examination of other transcription factors found in the glucagon cells showed normal
Pax6 and Nkx2.2 immunoreactivity, suggesting that Brn4 does not regulate these transcription factors. Pax6 mutant mice (pax6Sey/Sey), with a
natural inactivating mutation in pax6, have few endocrine cells but normal numbers of Brn4 and Nkx2.2 cells. The pancreatic phenotype of
the pax6 mutants can be rescued with a YAC clone containing the human Pax6 gene.
D 2004 Elsevier Inc. All rights reserved.Keywords: Pax6; Brn4; Transcription factors; Pancreas; Glucagon; Endocrine; Development; EmbryologyIntroduction
The hormones produced by the endocrine pancreas are
crucial for the maintenance of blood glucose homeostasis.
The balance between insulin and glucagon concentrations
precisely determines the glucose concentration in the blood
via insulin action on peripheral tissues and glucagon on the
liver. The glucagon cells are the first endocrine cells formed
in the developing pancreas starting between embryonic day
E9 to 9.5. Multiple transcription factors have been impli-
cated in the regulation of glucagon gene expression (Ander-
sen et al., 1999a,b; Hussain et al., 1997; Jin and Drucker,
1996; Liu et al., 2002; Ritz-Laser et al., 2002).0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.12.008
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E-mail address: shll@hagedorn.dk (R. Scott Heller).The Pax family of proteins share three conserved motifs
(Hill and Hanson, 1992), a paired domain near the amino
terminus and a paired-type homeodomain 3V to that, both of
which have DNA binding ability, and an octapeptide motif
lying in between (Mansouri et al., 1999). Pax6 has a paired
box DNA binding domain as well as a complete homeo-
domain but lacks the octapeptide motif and has been shown
to play major roles in regulating genes in forebrain, hind-
brain, nose, eye and pancreas. Pax6 binds to the insulin,
somatostatin, and the glucagon promoters and increases
gene transcription in combination with different partners
in the different cell types (Andersen et al., 1999a,b; Hussain
and Habener, 1999; Jin et al., 1997; Planque et al., 2001;
Sander et al., 1997). Small eye (Sey) is a naturally occurring
mutant of the pax6 gene of which several alleles have been
reported (SeySey, Sey1Neu) (Hill et al., 1991; Hill and Van
Heyningen, 1992). The precise levels of pax6 gene expres-
sion appears to be critical to cellular function in multiple
Table 1
Antisera used in this study
Antigen Species Dilution Source
R. Scott Heller et al. / Developmenta124tissues (Schedl et al., 1996). The original pax6Sey/Sey
mutants, when rescued with a human YAC construct with
various integrated copy numbers showed dramatic effects of
having either too much or too little Pax6. Analysis of
PAX77 mice showed that the YAC could completely rescue
the pax6Sey/Sey mutants, while pax130, which expressed
fewer copies of the human Pax6 YAC, was unable to rescue
completely (Schedl et al., 1996). Mice containing multiple
copies of the transgene had numerous eye abnormalitites but
no tumor formation was observed as has been seen in cell
lines overexpressing pax genes (Maulbecker and Gruss,
1993). The knockout of the pax6 gene in mice (St-Onge
et al., 1997) as well as the analysis of the pax61Neu/1Neu
mutant showed that the numbers of all four endocrine
hormone-producing cells were decreased and that islet
morphology was significantly altered (Sander et al., 1997).
Very few glucagon cells are found, suggesting that Pax6 is
crucial for glucagon gene expression.
Brn4/Pou3f4 is a POU-homeodomain gene that is critical
for the patterning of the mesenchymal compartment of the
inner ear and mutations in humans cause deafness (de Kok
et al., 1995; Phippard et al., 1999). Brn4 is expressed in the
adult pancreatic glucagon cells and has been shown to
directly regulate the glucagon gene promoter working with
Cdx2/3 (Hussain et al., 1997). Recent in vivo and in vitro
studies have shown that forced expression of brn4 is
sufficient to activate the glucagon gene but not a complete
a-cell phenotype (Hussain et al., 2002; Wang et al., 2001).
Interestingly, PC2 mutant mice contain cells that express
glucagon in the presence of Pdx1 and Nkx6.1, while lacking
Brn4 (Vincent et al., 2003).
In this study, we describe the analysis of Pax6, Isl1,
Brn4, Pdx1, Nkx6.1 and Nkx2.2 expression in the pancreas
during development and their relationship to the formation
of the pancreatic glucagon cells in both normal and several
strains of mutant mice, where evidence has been provided
for function in the glucagon producing a-cells.
Brn4 rabbit 1:400 Dr. M. Geof Rosenfeld,
UCSD, San Diego, CA
Brn4 rabbit 1:400 Dr. Aimee Ryan,
McGill Univ. Canada
Pdx1 253 rabbit 1:800 Dr. Joel Habener,
MGH, Boston, MA
Isl1 rabbit 1:500 Dr. Helena Edlund,
Umea˚, Sweden
Isl1 mouse 1:50 Developmental Studies
Hybridoma Bank
Pax6 rabbit 1:100 Babco, Richmond,
CA. (PRB278P)
Pax6 rabbit 1:300 S. Saule, France (Bg11)
Nkx2.2 rabbit 1:1000 Thomas Jessel,
Columbia Univ. NYC
Nkx6.1 rabbit 1:800 Hagedorn Research Institute
Insulin mouse 1:75 Novo Nordisk A/S, Denmark
Insulin guinea pig 1:200 ICN Chemicals
Ghrelin goat 1:500 Santa Cruz Biotechnology
Glucagon mouse 1:50 Novo Nordisk A/S, Denmark
PYY rabbit 1:500 Japan
PP guinea pig 1:20 Linco, St. Louis, MO
Somatostatin mouse 1:10 Novo Nordisk A/S, DenmarkMaterials and methods
Transgenic and knockout mice strains
Sey (Pax6 mutant) mice were a generous gift from Dr.
Veronica van Heyningen (Edinburgh, Scotland) and were
bred at M&B A/S, Ry, Denmark. Tissues from PAX77
(Schedl et al., 1996) and Brn4 knockout mice (Phippard
et al., 1999) were collected at various ages and fixed in
4% PFA overnight before shipping. The complete Brn4
open reading frame has been removed in this strain of
mice. All tissues were embedded in paraffin. The animal
maintenance, handling and experimentation were con-
ducted according to the guidelines of Novo Nordisk A/S
(Denmark), and according to the regulations as specified
under the Protection of Animals Act by the Authority in
Denmark.Immunocytochemistry
Sections were dewaxed in xylene and rehydrated through
a descending ethanol series. Antigen retrieval was accom-
plished through microwave treatment (two times for 5 min
at 600 W in 0.01 mol/l citrate buffer, pH 6.0) followed by
three washes in PBS. Nonspecific binding was blocked with
10% donkey nonimmune serum. For double immunofluo-
rescence, sections were incubated with primary antibodies
overnight. Secondary antibodies (fluorescein isothiocya-
nate-, Cy2-, and Texas Red-conjugated) were obtained from
Jackson ImmunoResearch (West Grove, PA). Double alka-
line phosphatase and HRP stainings were performed using
different substrates. See Table 1 for a list of the antisera used
in this study. Images were captured using a Hamamatsu
C5810 Color CCD camera and Image Pro Plus 4.5 software
interfaced with a PC computer.
RNAse protection assay
Mouse pancreas was harvested and stored in RNALater
(Ambion, Austin, TX, USA) until total RNA was isolated
using TRIZol reagent (5–10 ml/pancreas) according to
manufacturer’s instructions (Life Technologies, Gaithers-
burg, MD, USA). Mouse proglucagon and TATA Binding
Protein (TBP) (internal control) riboprobes were prepared as
described (Sund et al., 2001). Total RNA (30 Ag) was co-
hybridized with the proglucagon and TBP riboprobes using
the RPA Kit (Ambion) according to manufacturer’s instruc-
tions. Protected fragments were resolved on 5% SDS-urea
polyacrylamide gels and visualized by exposure to a Phos-
phorimager screen.
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mentaIslet hormone content
Hormone content was measured after acid-ethanol ex-
traction of protein from total pancreas as previously de-
scribed (Sund et al., 2001). After weighing, the pancreas
was homogenized in 10 volumes of acid ethanol (49 parts
ethanol to 1 part concentrated hydrochloric acid), incubated
at 4jC for 1 h and centrifuged. The supernatant was
quantitatively removed. Protein concentration in the super-
natant was determined using the Micro BCA Protein Assay
Reagent (Pierce Biotechnology, Inc, Rockford, IL, USA)
and glucagon and insulin concentrations were determined
by radioimmunoassay.
R. Scott Heller et al. / DevelopFig. 1. The Expression of Brn4 during mouse pancreas development. (A–C) B
Transcription factors are labeled in green and glucagon in red. White arrowheads
immunoreactive cells but not insulin immunoreactive cells at E14.5. (F) Isl-1 co
yellowish. (G– I) Brn4 co-localizes with all glucagon cells and most Isl-1 cells b
somatostatin immunoreactive cells. (L) Brn4 is not co-localized with Nkx6.1 cellGlucose tolerance testing
Mice were administered 2 g/kg glucose intraperitoneally
after an overnight fast. Blood was collected at 0, 15, 30, 60,
90 and 120 min. Blood glucose was measured by the
glucose oxidase method (Analox GL5). Serum was collect-
ed for insulin and glucagon under fasted conditions.
Radioimmunoassays
Radioimmunoassays for glucagon and insulin were car-
ried out by the Radioimmunoassay Core of the Penn
Diabetes Center.
l Biology 268 (2004) 123–134 125rn4, Isl-1 and Pax-6 are expressed in glucagon-producing cells at E10.5.
denote specific cell examples. (D, E) Brn4 co-localizes with all glucagon
-localizes with Brn4 in endocrine cells at E14.5. Co-localized cells appear
ut not insulin at E19.5. (J–K) Brn4 is expressed in a few PP cells but not
s. All images are 200 in magnification except F, which is 400 .
mental Biology 268 (2004) 123–134Statistics
Results are expressed as means F SE. Mean changes
were compared using the Student’s t test. P V 0.05 was
considered to be statistically significant.
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Expression of Brn4 during normal mouse pancreatic
development
The glucagon cells and their relationship to Brn4, Isl1
and Pax6 at E10.5, E14.5 and E19 were studied by doubleFig. 2. Expression of glucagon and transcription factors in normal, pax6sey/sey an
glucagon in red. White arrowheads denote specific cell examples. (A) PDX-1 an
exclusive sets of cells. Some glucagon cells (red) have low levels of PDX-1 (green
pax6sey/sey and brn-4 null mice. (D–F) Expression of Pax6 at E10.5. (D) Pax6 is
Pax6 immunoreactivity is not detected in pax6sey/sey mice but some glucagon cell
Brn4 expression at E10.5. (G) Brn4 is expressed in the glucagon-producing cells at
immunoreactivity is detectable in brn-4 null mice but glucagon cells still appear. (
some of which co-localize with glucagon. Isl-1/2 expression appears normal in pimmunohistochemical staining. At E10.5, Brn4, Isl1 and
Pax6 all co-localize with the early glucagon immunoreactive
cells (Figs. 1A–C). Isl1/2 also labels the surrounding
mesenchymal cells. Also, observed are cells that lack
glucagon immunoreactivity but stain positive for the tran-
scription factors. At E14.5, varying levels of Brn4 immu-
noreactivity are observed in the glucagon cells, while
numerous glucagon-negative cells are scattered in the epi-
thelium (Fig. 1D). There is no co-localization of Brn4 and
insulin (Fig. 1E). Brn4 and Isl1/2 co-localize in a subpop-
ulation of cells (Fig. 1F). At E19.5, Brn4 immunoreactivity
is restricted to the rim of the islets co-localizing with
glucagon and a occasionally with pancreatic polypeptide
(PP) cells (Figs. 1G, J). Brn4 does not co-localize withd brn-4 null mice at E10.5. Transcription factors are labeled in green and
d glucagon are expressed in the dorsal pancreatic bud and label mutually
). (B, C) PDX-1 expression and dorsal pancreatic bud formation is normal in
expressed in all glucagon cells but not all Pax6 cells express glucagon. (E)
s form. (F) Pax6 has a normal expression pattern in brn-4 null mice. (G–I)
E10.5. (H) Brn4 co-localizes with glucagon in pax6sey/sey mice. (I) No Brn4
J–L) Isl-1/2 is expressed in the mesenchyme and scattered endocrine cells,
ax6sey/sey and brn-4 null mice. All images are 200 in magnification.
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reactive cells are observed in the whole islet while the
population that express Brn4 are restricted to the rim of
the islet (Fig. 1I). There is no co-localization of Nkx6.1- and
Brn4-expressing cells (Fig. 1L).
Expression of transcription factors Brn4, Isl1/2, Pax6 and
Pdx1 in wild type, pax6sey/sey and Brn4 null mice at
embryonic day 10.5
Pdx1 immunoreactivity labels all the cells of the budding
epithelium but only a few of the glucagon cells (Figs. 2A–
C). Glucagon immunoreactive cells appear at E10.5 in
pax6sey/sey mice but they do not express Pax6 protein (Figs.Fig. 3. Expression of glucagon, insulin and transcription factors in normal, pax6sey/s
green and glucagon in red. White arrowheads denote specific cell examples. (A–C)
Few glucagon cells have any PDX-1 expression. (B) Few or no glucagon cells are de
expressed in brn-4 null mice. (D) Pax6 is expressed in scattered cells in the epit
detectable in the pax6sey/sey mice. (F) Pax6 and glucagon are normally expressed in b
labels most glucagon immunoreactive cells. (H) Brn4 immunoreactive cells are fou
detectable, while glucagon cells are still found in brn-4 null mice. (J–L) Nkx2.2
localizes with glucagon immunoreactive cells. Reduced numbers of Nkx2.2 cells a2B, E) and, similar to the wild type, some lack Brn4
immunoreactivity (Fig. 2H), while Isl1/2 immunoreactivity
is normal (Fig. 2K). Brn4 null mice have immunoreactive
glucagon cells that lack Brn4 but express Pax6 and Isl1/2
normally (Figs 2F, I and L).
Expression of glucagon, insulin and transcription factors in
normal, pax6sey/sey and brn4 null mice in E14.5 pancreas
At E14.5, the first strongly insulin immunoreactive cells
first appear. Numerous clusters of glucagon immunoreac-
tive cells appear at this time in the wild type and brn4 null
mice and these cells lack Pdx1 but expressed Pax6 (Figs.
3A, C). Few or no glucagon immunoreactive cells areey and brn-4 null mice in E14.5 pancreas. Transcription factors are labeled in
PDX-1 is expressed in most of the epithelium and some cell have high levels.
tected in the pax6sey/seymice at E14.5. (C) PDX-1 and glucagon are normally
helium and labels most all glucagon immunoreactive cells. (E) No Pax6 is
rn-4 null mice. (G) Brn4 is expressed in scattered cells in the epithelium and
nd in normal numbers in pax6sey/sey mice. (I) No Brn4 immunoreactivity is
is expressed in a normal pattern in pax6sey/sey and brn-4 null mice and co-
re observed in the pax6sey/sey mice. All images are 200 in magnification.
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mice (Fig. 3B). Numerous Pax6 immunoreactive cells are
found in the epithelium, of which most co-localize with the
glucagon immunoreactive cells in wild type and brn4
mutant mice, but both are absent from pax6sey/sey mice as
expected (Figs. 3D–F). Brn4 is expressed in the glucagon
cells as well as in some cells negative for glucagon (Fig.
3G). Brn4 immunoreactive cells are found in the pax6sey/sey
mice, while Brn4 immunoreactivity is absent in brn4 null
mice (Figs. 3H and I). Nkx2.2 is found in glucagon
immunoreactive cells but labels many more cells in the
growing epithelium in wild type and brn4 null mice, while
fewer Nkx2.2 cells are found in pax6sey/sey mice at this
stage of development (Figs. 3J–L). Isl1/2 was expressed in
a normal pattern in pax6sey/sey and brn4 null mice (data not
shown). Insulin and glucagon cells are scattered throughout
the epithelium at E14.5 in wild type and brn4 null mice,
while in pax6sey/sey mice, these cells are very rare (Figs.
4A–C). Pdx1 is found in insulin-positive cells in wild type
and brn4 null mice but also labels additional cells in the
epithelium (Figs. 4D, F). Despite the near complete lack of
endocrine cells at E14.5, Pdx1 is still expressed in the
epithelium in pax6sey/sey mice (Fig. 4E). Analysis of
ghrelin, a hormonal cell type transiently expressed in the
mouse pancreas and shown to be related to the a-cell
lineage (R.S.H., submitted for publication), showed that
ghrelin cells are scattered in the epithelium in wild type,
pax6sey/sey and brn4 null mice, and occasionally co-localize
with glucagon (data not shown).Fig. 4. Expression of glucagon, insulin and PDX-1 in normal, pax6sey/sey and brn-4
glucagon in red. White arrowheads denote specific cell examples. (A) Insulin and g
other. (B) Pax6sey/sey mice have decreased insulin immunoreactive cells and little o
normal pattern in brn-4 null mice. (D) Insulin immunoreactivity is detectable in sca
and at higher levels in the insulin immunoreactive cells in pax6sey/sey and brn-4 nul
images are 200 in magnification.Expression of glucagon, insulin and transcription factors in
normal and pax6sey/sey mice in E19 pancreas
When mice develop to the embryonic age of E19, the
endocrine pancreas is beginning to mature and all four
hormone cell types appear. To increase our sensitivity, we
chose to do a series of immunoperoxidase stainings.
While few insulin or glucagon cells are detected in the
pax6sey/sey mice by immunofluorescence (data not shown),
using the more sensitive peroxidase method, we could
detect significant numbers of insulin and glucagon immu-
noreactive cells at E19 (Figs. 5D, J), but they are reduced
in number compared to wild-type animals (Figs. 5A, G).
Isl1/2 is co-localized with all the hormone-producing cells
(Jensen et al., 2000), while Brn4 co-localizes mainly with
the glucagon immunoreactive cells and not the insulin
cells. In the pax6sey/sey mice, Isl1/2 and Brn4 are
expressed in the endocrine areas, which appear as elon-
gated structures rather than round islet like structures
(Figs. 5E, F) as compared to wild-type animals (Figs.
5B, C). Isl1 and Brn4 cells were used to quantitate the
endocrine areas as ratios of endocrine cells in wild type
and pax6sey/sey mice. The number of Brn4 cells in wild
type and pax6sey/sey mice revealed a decrease in overall
endocrine areas but a similar number of Brn4 cells per
area (data not shown). The size and shape of the endo-
crine areas were also illustrated by numerous Nkx2.2- and
Nkx6.1-expressing cells found in the elongated endocrine
structures (Figs. 5H–L).
l Biology 268 (2004) 123–134null mice in E14.5 pancreas. Transcription factors are labeled in green and
lucagon cells are scattered in the epithelium and do not co-localize with each
r no glucagon immunoreactivity. (C) Insulin and glucagon are expressed in a
ttered cells that express PDX-1. (E, F) PDX-1 is expressed in the epithelium
l mice. Yellow nuclei, in most cases, are autofluorescent red blood cells. All
Fig. 5. Expression of hormones and transcription factors in wild type and pax6sey/sey mice at E19. Peroxidase staining of E19 wild type and pax6sey/sey mice for
glucagon, Brn4 and Isl-1/2 on adjacent sections. (A, B) Glucagon and Brn4 co-localize but some non-glucagon immunoreactive cells have high levels of Brn4
immunoreactivity. (C) Isl-1/2 marks all the endocrine cells in the islet. Note, this is not an adjacent section. (D–F) Very few glucagon cells are found in the
islet structures as localized by Isl-1/2. Brn4 cells are expressed in normal numbers. (G– I) Peroxidase staining of E19 wild type and pax6sey/sey mice for insulin,
Nkx6.1 and Nkx2.2 on adjacent sections. (G) Insulin immunoreactive cells are restricted to the islet. Note, this is not adjacent section. (H, I) Nkx6.1 marks the
core of the forming islets while Nkx2.2 labels all endocrine cells. (J) Decreased numbers of insulin immunoreactive cells are found at E19. (K) Nkx6.1
immunoreactive cells are found at higher numbers than insulin cells. (L) Nkx2.2 labels all the cells in the endocrine areas. Images A–F is 200 and G–L is
100 magnification.
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Pax77 mice
Several mouse models carrying pax6 mutations have
been described in the literature (Hill and Van Heyningen,
1992). Pax6sey/sey/TG77 mice were described as having a
complete rescue of the eye phenotype but the pancreas was
never examined (Schedl et al., 1996). The epitopes recog-
nized by the Pax6 antiserum used in this study are depicted
in Fig. 6A. Pax6sey/sey/TG77 mice have a complete rescue
of Pax6 immunoreactivity. Peroxidase stainings using thePRB278P c-terminal antiserum, showed strong nuclear
immunoreactivity in the nucleus of the pancreatic islet in
4-week-old mice (Figs. 6B, C). Normal islet architecture
and insulin and glucagon immunoreactivity was also re-
covered (data not shown). Three different rescued mice
were examined for glucagon, PP and Brn4 expression. Brn4
immunoreactivity was normal in all three mice carrying the
TG77 transgene and glucagon expression and nearly normal
islet architecture were observed (Figs. 6D–F). Normal
numbers of insulin (data not shown), glucagon and PP cells
were found in the TG77 rescued mice (Figs. 6G–I).
Fig. 6. Rescue of Pax6 and hormone expression in islets of pax6sey/sey/TG77mice. (A) Diagram of the Pax6 gene in wild type, sey1Neu and seymice. Sey1Neu have
an frame shift mutation which results in a Pax6 protein that contains a functional paired domain (PD) and homeodomain (HD) but lacks most of the PST domain
required for transactivation. Seymice have a mutation, which results in a Pax6 protein that lacks the HD and PST domains but has a complete PD. The antiserums
used in this study to detect Pax6 are denoted by the symbol. (B, C) Rescue of Pax6 immunoreactivity in islets of 4-week-old pax6/TG77 mice. Rescue of
hormone expression in postnatal day 1 pax6sey/sey/TG77mice. (D–F) Brn4 (green) and glucagon (red) immunoreactivity in three different pax6sey/sey/TG77mice.
Nearly normal islet structures is observed and glucagon expression has returned. (G–I) Glucagon (red) and pancreatic polypeptide (green) immunoreactivity in
three different pax6sey/sey/TG77 mice. Glucagon and pancreatic polypeptide cells are observed in the rim of rescued mice. Peroxidase images are 100 and
immunofluorescence images 200 in magnification.
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glucose are normal in 4-week-old brn4 null mice
Brn4 is a transcription factor that is expressed nearly
exclusively in the glucagon cells from the earliest stage of
pancreatic development. A knockout mouse was previously
produced (Phippard et al., 1999) and we have analyzed the
pancreatic phenotype in 4-week-old mice. Double immuno-fluorescent stainings were performed for glucagon in com-
bination with pancreatic polypeptide (Fig. 7A), somatostatin
(Fig. 7B), IAPP (Fig. 7C) and insulin (Fig. 7D). All four
hormones were normally expressed and showed no dual
localization with glucagon in wild type or brn4 null animals.
To examine if the h-cell marker, GLUT2 was improperly
expressed in brn4 null mice, double stainings were per-
formed. GLUT2 co-localized only with the insulin immu-
Fig. 7. Hormone expression is normal in 4-week-old brn-4 null mice. (A) Glucagon (red) and pancreatic polypeptide (green) immunoreactivity in wild type
(+/+) and brn-4 null mice ( / ). The pattern and expression is the same in wild type and brn-4 null mice. There is no co-expression of PP and glucagon.
(B) Glucagon and somatostatin (green) immunoreactivity in wild type (+/+) and brn-4 null mice ( / ). The pattern and expression is the same in wild
type and brn-4 null mice. There is no co-expression of SS and glucagon. (C) Glucagon and IAPP (green) immunoreactivity in wild type (+/+) and brn-4 null mice
( / ). The pattern and expression is the same in wild type and brn-4 null mice. There is no co-expression of IAPP and glucagon. (D) Glucagon and insulin
(green) immunoreactivity in wild type (+/+) and brn-4 null mice ( / ). The pattern and expression is the same in wild type and Brn4 null mice. There is no co-
expression of insulin and glucagon. (E) Insulin (green) and Glut-2 (red) immunoreactivity in wild type (+/+) and brn-4 null mice ( / ). The pattern and
expression is the same in wild type and brn-4 null mice. No glut-2 expression was observed in the islet rim. All images are 200 in magnification.
R. Scott Heller et al. / Developmental Biology 268 (2004) 123–134 131noreactive h-cells in wild type and brn4 null mice (Fig. 7E).
Ghrelin cells were not observed in wild type or brn4 null
mice at 4 weeks of age (data not shown).
Hormone immunoreactivity appeared normal in all brn4
null animals examined but this is not informative regarding
whether glucagon gene expression or hormone content was
normal in the pancreatic islets of Brn4 null mice. RNA was
isolated from 4-week-old wild type and brn4 null mice and
RNase protection assay was performed. In four animals,
glucagon RNA levels were indistinguishable from wild-type
animals (Fig. 8A). Serum was removed from non-fasted
animals, the concentrations of glucagon and insulin were
determined by radioimmunoassay. No significant differen-
ces were found between control (+/?) and brn4 null mice
( / ) (Fig. 8B). Whole pancreatic insulin and glucagon
content was also determined and no significant differenceswere observed between the two groups of animals (Fig. 8B).
To examine the animals’ ability to regulate blood glucose, a
glucose tolerance test was performed. After intraperitoneal
administration of (2 g/kg body weight) glucose, blood
samples were taken at 0, 15, 30, 60, 90 and 120 min. No
significant differences were observed between brn4 null
mice and control mice (Fig. 8C).Discussion
Brn4 marks the earliest glucagon cells and is expressed
before Pax6
Brn4 was first described in the pancreatic a-cells and
more recently, shown to be able to activate glucagon gene
Fig. 8. Glucagon gene expression and islet hormone secretion are normal in
brn-4 null mice. (A) RNase Protection Assay for mouse proglucagon
mRNA levels. N = 4 wild type (+/+), N = 4 brn-4 ( / ) null mice. P,
undigested riboprobes; L, ladder. TBP is a loading control. (B) Pancreatic
content and serum hormone concentrations in 4-week-old wild type (+/+)
and brn-4 ( / ) null mice. Hormone content is normalized to protein
concentration. No differences were detected between wild type (+/?) and
null ( / ) mice. For serum insulin, N = 4 for each group. For serum
glucagon, N = 6 (+/?), N = 8 ( / ) mice. For pancreatic insulin and
glucagon content, N = 4 in each group. (C) Intraperitoneal glucose tolerance
tests in 4-week-old normal (+/?) and brn-4 ( / ) null mice. No
differences among wild type, heterozygous and null mice were observed,
nor between male and female mice. N = 7 for control brn-4 (+/?) (4F, 3M)
and N = 8 for brn-4 ( / ) (4F, 4M).
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insulinoma cells (Hussain et al., 1997, 2002; Wang et al.,
2001). We have presented in this study the first in-depth
examination of brn4 expression during development and
shown that Brn4 is a very early glucagon cell marker,beginning before Pax6 and Isl1. Notably, a few glucagon-
positive cells in both wild type and pax6 mutant mice lack
Brn4 immunoreactivity. The significance of this remains
unclear. We have demonstrated that Brn4 as well as Pax6
are expressed in the early glucagon-expressing cells at E10.
We have previously established that Isl1 is activated before
Pax6 in the pancreas and in addition in this study show that
Brn4 is likely expressed before Isl1 and Pax6 in the
glucagon cells as we observe cells that are Brn4+Isl1
and Isl1+Pax6 cells but we never observe cells that are
Isl1Pax6+ cells (Jensen et al., 2000). While, Pdx1, a
marker of the early pancreatic epithelium is occasionally
found in some of these earliest glucagon cells, current data
suggest that these are small amounts of remaining Pdx1
from the now differentiated cells, as glucagon cells after
E16 never express Pdx1. Nkx2.2, a NK2 homeobox tran-
scription factor has been shown to be important for devel-
opment of h-cells, but also for a- and PP-cells (Sussel et al.,
1998). As reported by Sussel et al., we observed that
Nkx2.2 co-localizes with the a-, h- and PP-cells. Brn4
could be exclusively localized to the glucagon producing a-
cells, as the Brn4+PP-cells can be explained by the presence
of rare glucagon+PP+ cells in normal mouse pancreas (not
shown). Brn4 is never co-localized in insulin or somato-
statin cells.
Glucagon can be expressed in the absence of Brn4
A very detailed analysis of the Brn4 knockout mice
pancreas during development showed a completely normal
appearance of all endocrine cells and transcription factors
analyzed. This was somewhat surprising because overex-
pression of Brn4 by using the Pdx1 promoter was capable of
driving sustained expression of glucagon in h-cells. Inter-
estingly, this phenotype was not observed in mice express-
ing brn4 from the mouse insulin promoter (Hussain et al.,
2002). This suggests that Brn4 acts at an early developmen-
tal stages but is not essential for the glucagon cell fate
determination. In the knockout mice, it is possible that
upregulation of other POU transcription factors could re-
place Brn4. However, a screen for additional POU domain-
containing transcription factors by degenerate PCR in aTC
cells did not reveal other POU domain factors (Hussain et
al., 1997). Examination of other transcription factors found
in the glucagon cells showed normal Pax6 and Nkx2.2
immunoreactivity, suggesting that Brn4 does not regulate
these transcription factors.
Regulation of pancreatic hormone secretion does not
require Brn4
A detailed examination of RNA, peptide content and
secretion of insulin and glucagon was performed in Brn4
null mice. These data revealed that Brn4 was not a critical
transcription factor that affected expression, biosynthesis or
secretion of glucagon or insulin in vivo.
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Pax6 gene can rescue the pancreatic phenotype
Pax6 has been shown to be an important transcription
factor in the pancreas. Analysis of pax61Neu/1Neu mice
(Sander et al., 1997) and pax6 null mice (St-Onge et al.,
1997) showed that these mice have decreased numbers of
endocrine cells and especially decreased or absent are the
glucagon cells. Our pancreatic analysis of the pax6sey/sey
mice shows a very similar phenotype to that reported for the
pax61Neu/1Neu mice (Sander et al., 1997). During endocrine
development, Pax6 is expressed in all the endocrine cells in
the pancreas, including the ghrelin cell (R.S.H., submitted
for publication). It has been suggested that expression of
Pax4 and Pax6 together during development leads to the
expression of h-, y-, g-cells and cells expressing only Pax6
differentiate into a-cells (St-Onge et al., 1997). However,
the fraction of Brn4+cells in relation to total endocrine cells
(Isl1+) is apparently normal in pax6sey/sey mice, suggesting
that a-cells are formed in normal numbers in pax6 mutants
but that these cells fail to transcribe the glucagon gene to
any significant extent. One could postulate that the glucagon
cells are more affected by the loss of pax6 due to the
presence of two conserved sites in the proximal promoter,
while both the insulin and somatostatin promoters only have
one (Andersen et al., 1999a,b; Hussain et al., 1997; Sander
et al., 1997). Since we observed many Isl1-, Nkx2.2-,
Nkx6.1- and Brn4-positive cells in the elongated endocrine
areas but few cells expressed terminal markers (hormones),
this suggests that Pax6 is critical for the expression of the
hormone genes but not for specification of the cells as such.
In addition to observing a decrease in endocrine cells in our
analysis of the pax6sey/sey mice, we observed that the
majority of the cells that fail to express any of the classical
islet hormones express ghrelin. Analysis of human pancreas
and postnatal mouse pancreas showed that Pax6 expression
is lost in the ghrelin cells after birth (R.S.H., submitted for
publication). Since the a-, h- and y-cells are dependent on
Pax6, it is possible that in the presence of Brn4 and Nkx2.2
and other transcription factors, the cells default to ghrelin
gene expression in the absence of Pax6.
Analysis of PAX77 mice have shown that the human pax6
YAC clone is able to completely rescue the eye phenotype of
pax6 mutants (Schedl et al., 1996). Our analysis of the
pancreas showed that Pax6 immunoreactivity, islet structure
and hormone expression was completely normalized.
In conclusion, we have shown that pax6 but not brn4 is
required for the proper differentiation of a-cells as well as
other endocrine cell types in the pancreas but pax6 does not
seem to be required for the specification of the a-cell as such.
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